WA
GSK icon

Wheatland Advisors’s GSK GSK Stock Holding History

Wheatland Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,818
Closed -$342K – 59
2019
Q4 		$342K Sell
5,818
-319
-5% -$17.7K 0.44% 70
2019
Q3 		$327K Sell
6,137
-8,018
-57% -$412K 0.3% 76
2019
Q2 		$708K Buy
14,155
+1
+0% +$50 0.53% 58
2019
Q1 		$739K Sell
14,154
-662
-4% -$33.1K 0.56% 58
2018
Q4 		$708K Buy
14,816
+2
+0% +$98 0.62% 54
2018
Q3 		$744K Buy
14,814
+1
+0% +$51 0.56% 56
2018
Q2 		$746K Buy
14,813
+209
+1% +$10.5K 0.6% 56
2018
Q1 		$713K Buy
14,604
+2
+0% +$93 0.59% 57
2017
Q4 		$647K Buy
14,602
+1
+0% +$46 0.52% 59
2017
Q3 		$741K Buy
14,601
+1
+0% +$51 0.63% 51
2017
Q2 		$787K Buy
14,600
+2
+0% +$107 0.71% 52
2017
Q1 		$769K Hold
14,598
– – 0.69% 52
2016
Q4 		$703K Buy
14,598
+1
+0% +$49 0.62% 55
2016
Q3 		$787K Sell
14,597
-42
-0.3% -$2.3K 0.74% 50
2016
Q2 		$793K Buy
14,639
+1
+0% +$53 0.76% 47
2016
Q1 		$742K Buy
14,638
+2
+0% +$100 0.76% 48
2015
Q4 		$738K Buy
14,636
+1
+0% +$51 0.75% 46
2015
Q3 		$703K Buy
14,635
+1
+0% +$52 0.76% 46
2015
Q2 		$762K Sell
14,634
-159
-1% -$8.95K 0.73% 50
2015
Q1 		$853K Buy
14,793
+2
+0% +$115 0.85% 46
2014
Q4 		$790K Buy
14,791
+1
+0% +$56 0.77% 51
2014
Q3 		$850K Buy
14,790
+1
+0% +$61 0.85% 45
2014
Q2 		$1.66M Buy
14,789
+1
+0% +$68 1.51% 27
2014
Q1 		$988K Hold
14,788
– – 1.01% 41
2013
Q4 		$987K Buy
+14,788
New +$959K 1.03% 42

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Wheatland Advisors's GSK Position: Q1 2020 in Review

Wheatland Advisors sold out of GSK (GSK) in Q1 2020, closing a stake of 5,818 shares — an estimated $342K sold.

Wheatland Advisors first reported a position in GSK in Q4 2013 and held it in 25 quarters. The position peaked at $1.66M in Q2 2014. 817 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

  • Wheatland Advisors reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
  • Wheatland Advisors sold 5,818 GSK shares in Q1 2020, an estimated $342K.
  • Wheatland Advisors first reported a position in GSK in Q4 2013 and held it in 25 quarters.
  • Wheatland Advisors's GSK position peaked at $1.66M in Q2 2014.
  • 817 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Wheatland Advisors's 13F filing for Q1 2020, filed 8 May 2020.